Advancing neoadjuvant immunotherapy for lung cancer

Nat Med. 2023 Mar;29(3):533-534. doi: 10.1038/s41591-023-02246-2.

Authors

Michael Conroy¹, Patrick M Forde²

Affiliations

¹ Bloomberg-Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA.
² Bloomberg-Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA. pforde1@jhmi.edu.

PMID: 36928820
DOI: 10.1038/s41591-023-02246-2

No abstract available

MeSH terms

Humans
Immunotherapy
Lung Neoplasms* / therapy
Neoadjuvant Therapy*